Clinical Trial

Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction

Study acronym: INSIGHT-STEMI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
STEMI represents the subtype of ACS with the worst prognosis, associated with high mortality and an elevated risk of complications. The use of IVI guidance holds the potential to reduce the incidence of MACE. In previous studies, there has been limited research on intravascular imaging in the context of primary revascularization procedures for STEMI, and no large-scale cohort study has compared the differences in clinical outcomes between IVI-guided and angiography-guided primary revascularization. Therefore, we conducted this large-scale randomized controlled trial to compare IVI-guided primary PCI versus coronary angiography-guided primary PCI in patients with STEMI.
Protocol Amendment History 1 change
notable Enrollment increased: 1956 -> 2488 participants 2026-06-19
Trial Details
NCT Number NCT07616024
Lead Sponsor Shanghai Zhongshan Hospital
Collaborators: Shanghai 10th People's Hospital
Conditions STEMI, PCI
Enrollment 2,488 participants
Start Date 2026-06-01
Primary Completion 2032-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-18